BCL6 and skin squamous cell carcinoma: Additionally, in a retrospective study of 33 cSCC patients treated with a PD-1 inhibitor, responders were found to have low-copy gains in the chromosome 3q21-27 region containing ETV5, PIK3CA, and BCL6 [23].